Literature DB >> 26341705

Molecular characterization of carbapenem-resistant Pseudomonas aeruginosa strains isolated from patients with urinary tract infections in Southern Poland.

Monika Pobiega1, Joanna Maciąg2, Agnieszka Chmielarczyk3, Dorota Romaniszyn3, Monika Pomorska-Wesolowska4, Grzegorz Ziolkowski5, Piotr B Heczko3, Malgorzata Bulanda3, Jadwiga Wojkowska-Mach3.   

Abstract

Due to the clinical threat posed by multidrug-resistant (MDR) Pseudomonas aeruginosa and importance of virulence factors produced in infection, 21 carbapenem-resistant P. aeruginosa were analyzed. 42.8% metallo-beta-lactamases-positive strains were identified. 85.7% of strains were meropenem resistant. 14.2% of strains were MDR; 38%, extensively drug-resistant (XDR). ExoY was present in all strains; exoT, in 95.2%; exoS, in 90.5%; exoU, in 47.6%. Eight XDR strains were typed using multilocus sequence typing: 4 as ST235, 2 as ST260, 2 as ST654 and ST234. MDR P. aeruginosa were isolated from hospitalized patients and among those from the community. Our study demonstrates the serious clinical issues posed by MDR P. aeruginosa and underscores the need for new treatment.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Carbapenem-resistance; MLST; Pseudomonas aeruginosa; exo

Mesh:

Substances:

Year:  2015        PMID: 26341705     DOI: 10.1016/j.diagmicrobio.2015.07.022

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  12 in total

1.  Multidrug-Resistant Sequence Type 235 Pseudomonas aeruginosa Clinical Isolates Producing IMP-26 with Increased Carbapenem-Hydrolyzing Activities in Vietnam.

Authors:  Tatsuya Tada; Pham Hong Nhung; Tohru Miyoshi-Akiyama; Kayo Shimada; Mitsuhiro Tsuchiya; Doan Mai Phuong; Nguyen Quoc Anh; Norio Ohmagari; Teruo Kirikae
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

2.  Evaluation of Aminoglycoside and Carbapenem Resistance in a Collection of Drug-Resistant Pseudomonas aeruginosa Clinical Isolates.

Authors:  Selina Y L Holbrook; Sylvie Garneau-Tsodikova
Journal:  Microb Drug Resist       Date:  2017-12-20       Impact factor: 3.431

3.  Colistin-Nonsusceptible Pseudomonas aeruginosa Sequence Type 654 with blaNDM-1 Arrives in North America.

Authors:  L F Mataseje; G Peirano; D L Church; J Conly; M Mulvey; J D Pitout
Journal:  Antimicrob Agents Chemother       Date:  2016-01-11       Impact factor: 5.191

4.  Microbiology and Drug Resistance of Pathogens in Patients Hospitalized at the Nephrology Department in the South of Poland.

Authors:  Mikołaj Michno; Antoni Sydor; Marta Wałaszek; Władysław Sułowicz
Journal:  Pol J Microbiol       Date:  2018

5.  Molecular detection of virulence factors and biofilm formation in Pseudomonas aeruginosa obtained from different clinical specimens in Bandar Abbas.

Authors:  Nima Bahador; Saeed Shoja; Foroogh Faridi; Banafsheh Dozandeh-Mobarrez; Fatemeh Izadpanah Qeshmi; Sedigheh Javadpour; Sedigheh Mokhtary
Journal:  Iran J Microbiol       Date:  2019-02

6.  Prevalence of the Genes Associated with Biofilm and Toxins Synthesis amongst the Pseudomonas aeruginosa Clinical Strains.

Authors:  Tomasz Bogiel; Dagmara Depka; Mateusz Rzepka; Joanna Kwiecińska-Piróg; Eugenia Gospodarek-Komkowska
Journal:  Antibiotics (Basel)       Date:  2021-02-28

7.  Carbapenem-Resistant Pseudomonas aeruginosa Strains-Distribution of the Essential Enzymatic Virulence Factors Genes.

Authors:  Tomasz Bogiel; Małgorzata Prażyńska; Joanna Kwiecińska-Piróg; Agnieszka Mikucka; Eugenia Gospodarek-Komkowska
Journal:  Antibiotics (Basel)       Date:  2020-12-24

8.  Exoenzyme Y Contributes to End-Organ Dysfunction Caused by Pseudomonas aeruginosa Pneumonia in Critically Ill Patients: An Exploratory Study.

Authors:  Brant M Wagener; Naseem Anjum; Sarah C Christiaans; Morgan E Banks; Jordan C Parker; Adam T Threet; Rashidra R Walker; Kayla D Isbell; Stephen A Moser; Troy Stevens; Mikhail F Alexeyev; Jonathon P Audia; Wito Richter; Kierra S Hardy; Lina Abou Saleh; Charity Morgan; Jean-François Pittet
Journal:  Toxins (Basel)       Date:  2020-06-04       Impact factor: 4.546

9.  Multidrug resistant Pseudomonas aeruginosa in Estonian hospitals.

Authors:  Kaidi Telling; Mailis Laht; Age Brauer; Maido Remm; Veljo Kisand; Matti Maimets; Tanel Tenson; Irja Lutsar
Journal:  BMC Infect Dis       Date:  2018-10-11       Impact factor: 3.090

10.  Detection of diverse carbapenem and multidrug resistance genes and high-risk strain types among carbapenem non-susceptible clinical isolates of target gram-negative bacteria in Kenya.

Authors:  Lillian Musila; Cecilia Kyany'a; Rosslyn Maybank; Jason Stam; Valerie Oundo; Willie Sang
Journal:  PLoS One       Date:  2021-02-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.